Refractory Gastroesophageal Reflux Disease: A Management Update

Refractory Gastroesophageal Reflux Disease: A Management Update

Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving symptoms in most cases, although up to 40% of GERD patients do not respond adequately to PPI therapy. Refractory GERD (rGERD) is...

Full description

Bibliographic Details
Main Authors: Francesco Rettura, Francesco Bronzini, Michele Campigotto, Christian Lambiase, Andrea Pancetti, Ginevra Berti, Santino Marchi, Nicola de Bortoli, Frank Zerbib, Edoardo Savarino, Massimo Bellini
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Medicine
Subjects:
gastroesophageal reflux disease (GERD)
refractory GERD (rGERD)
24-h multichannel intraluminal impedance-pH (MII-pH)
proton pump inhibitors (PPIs)
laparoscopic antireflux surgery (LARS)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.765061/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.765061/full

Similar Items